Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial

被引:0
|
作者
Danilo Moyses Jorge
José Edísio da Silva Tavares Neto
Omero Benedicto Poli-Neto
Ingrid U. Scott
Rodrigo Jorge
机构
[1] University of São Paulo,Department of Ophthalmology, Ribeirão Preto Medical School
[2] University of São Paulo,Department of Gynecology and Obstetrics, Ribeirão Preto Medical School
[3] Penn State College of Medicine,Departments of Ophthalmology and Public Health Sciences
来源
International Journal of Retina and Vitreous | / 7卷
关键词
Retina; Vitreous; Bevacizumab; Vitrectomy; Vitreous Hemorrhage;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial
    Jorge, Danilo Moyses
    Tavares Neto, Jose Edisio da Silva
    Poli-Neto, Omero Benedicto
    Scott, Ingrid U.
    Jorge, Rodrigo
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2021, 7 (01)
  • [2] Intravitreal Bevacizumab for Postoperative Vitreous Hemorrhage after Vitrectomy for Proliferative Diabetic Retinopathy
    Walia, Harpreet
    Rothman, Richard J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [3] Pars plana vitrectomy in vitreous hemorrhage with or without Intravitreal Bevacizumab: A comparative overview
    Faisal, Syed Muhammad
    Tahir, Muhammad Ali
    Cheema, Alyscia Miriam
    Anjum, Muhammad Ijaz
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2018, 34 (01) : 221 - 225
  • [4] Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study
    Irini Chatziralli
    Eleni Dimitriou
    George Theodossiadis
    Evgenia Bourouki
    Eleni Bagli
    George Kitsos
    Panagiotis Theodossiadis
    International Ophthalmology, 2020, 40 : 841 - 847
  • [5] Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study
    Chatziralli, Irini
    Dimitriou, Eleni
    Theodossiadis, George
    Bourouki, Evgenia
    Bagli, Eleni
    Kitsos, George
    Theodossiadis, Panagiotis
    INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (04) : 841 - 847
  • [6] Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage
    Spaide, Richard F.
    Fisher, Yale L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (03): : 275 - 278
  • [7] Effect of Intravitreal Conbercept Injection on Complications of Pars Plana Vitrectomy in Patients with Proliferative Diabetic Retinopathy
    Ding, Yuzhi
    Su, Na
    Luan, Jie
    Ni, Yan
    Sun, Zilin
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (04):
  • [8] Intravitreal Avastin as an adjunct in patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy
    Zaman, Yawar
    Aziz-ur-Rehman
    Memon, Abdul Fattah
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2013, 29 (02) : 590 - 592
  • [9] Visual Outcomes of Pars Plana Vitrectomy Alone or with Intravitreal Bevacizumab in Patients of Diabetic Vitreous Haemorrhage
    Haseeb, Uzma
    Aziz-ur-Rehman
    Haseeb, Muhammad
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2019, 29 (08): : 728 - 731
  • [10] Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial
    Abd Elhamid, Ahmed Hosni
    Mohamed, Ahmed Abd El Alim
    Khattab, Abeer Mohamed
    BMC OPHTHALMOLOGY, 2020, 20 (01)